Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 54Lung Neoplasms 29Colorectal Neoplasms 24Prostatic Neoplasms 23Colonic Neoplasms 16Rectal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Neoplasms 13Uterine Cervical Neoplasms 12Lymphoma 11Urinary Bladder Neoplasms 8Leukemia 8Endometrial Neoplasms 8Depression 8Pancreatic Neoplasms 7Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Breast Carcinoma In Situ 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pain 6Multiple Myeloma 6Melanoma 6Hematologic Neoplasms 6Carcinoma, Ovarian Epithelial 6Anxiety Disorders 6Obesity 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematopoietic and Lymphatic System Neoplasm 5Fatigue 5Burkitt Lymphoma 5

Interventions

sotrovimab 1ciclesonide 1Standard of Care 1Procalcitonin 1Practice Guidelines as Topic 1Nivolumab 1Niclosamide 1Methods 1Interviews as Topic 1Immune Checkpoint Inhibitors 1High-Intensity Interval Training 1Exercise 1Educational Status 1Early Intervention, Educational 1Cholecalciferol 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lupus Erythematosus, Systemic × Early Intervention, Educational × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡